Information Provided By:
Fly News Breaks for March 15, 2016
CAH
Mar 15, 2016 | 07:08 EDT
Cowen analyst Charles Rihyee downgraded Cardinal Health to Market Perform saying he sees limited growth drivers. Rihyee said the 15+ year supercycle of generic introductions is coming to an end and expects a deceleration in generic introductions in 2016, and turning into headwinds in 2017 and further in 2018. The analyst does not expect generic inflation to return anytime soon due to the FDA's recent clearance of the ANDA backlog, and does not think it will accumulate again. Rihyee lowered his price target on Cardinal Health shares to $90 from $99.
News For CAH From the Last 2 Days
There are no results for your query CAH